EXHIBIT 99.1
Published on December 16, 2021
Exhibit 99.1
Form 51-102F3
Material Change Report
| Item 1 | Name and Address of Company |
Mind Medicine (MindMed) Inc. (the “Company”)
1055 West Hastings Street, Suite 1700
Vancouver, British Columbia
V6E 2E9
| Item 2 | Date of Material Change |
December 13, 2021
| Item 3 | News Release |
On December 14, 2021, a news release was disseminated through the newswire services of GlobalNewswire and subsequently filed on SEDAR at www.sedar.com.
| Item 4 | Summary of Material Change |
On December 13, 2021, the Company appointed (i) Robert Barrow as Chief Executive Officer and a director of the Company, (ii) Carol Vallone as Chair of the board of directors, (iii) Andreas Krebs as Vice Chair of the board of directors, and Perry Dellelce has ceased to be a director and Chair of the board of directors.
| Item 5 | Full Description of Material Change |
| 5.1 | Full Description of Material Change |
On December 13, 2021, the Company appointed (i) Robert Barrow as Chief Executive Officer and a director of the Company, (ii) Carol Vallone as Chair of the board of directors, (iii) Andreas Krebs as Vice Chair of the board of directors, and Perry Dellelce has ceased to be a director and Chair of the board of directors.
| 5.2 | Disclosure for Restructuring Transactions |
Not Applicable.
| Item 6 | Reliance on subsection 7.1(2) of National Instrument 51-102 |
Not Applicable.
| Item 7 | Omitted Information |
Not Applicable.
| Item 8 | Executive Officer |
For further information, please contact Rob Barrow, Chief Executive Officer of the Company, at 212-220-6633.
| Item 9 | Date of Report |
December 16, 2021.